Coya Therapeutics (COYA) Restructuring Costs (2024 - 2026)
Coya Therapeutics (COYA) posted Restructuring Costs of $1.3 million for Q1 2026, down 13.07% sequentially from $1.5 million in Q4 2025, and down 3.3% YoY from $1.3 million in Q1 2025.
Coya Therapeutics (COYA) Restructuring Costs (2024 - 2026) Analysis & Trends
Coya Therapeutics has reported Restructuring Costs for 3 years, with the latest figure at $1.3 million in Q1 2026.
- Quarterly Restructuring Costs fell 3.3% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.5 million (up 23.66% YoY) and the FY2025 annual result came in at $5.5 million, up 20.27% from the prior year.
- Restructuring Costs fell to $1.3 million in Q1 2026 per COYA's latest filing, from $1.5 million in the prior quarter.
- Over five years, Restructuring Costs peaked at $1.5 million in Q2 2025 and troughed at $991941.0 in Q4 2024.
- A 3-year average of $1.3 million and a median of $1.3 million in 2026 frame the typical range for Restructuring Costs.
- The widest YoY moves for Restructuring Costs: up 49.66% in 2025, down 10.83% in 2025.
- Over 3 years, Restructuring Costs stood at $991941.0 in 2024, then jumped by 49.66% to $1.5 million in 2025, then fell by 13.07% to $1.3 million in 2026.
- According to Business Quant data, Restructuring Costs over the past three periods registered $1.3 million, $1.5 million, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.29 Bn | 132.43 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.58 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn |
| 4 | Moderna | 61.87 Bn | 56.73 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.90 Bn | 10.51 Bn | 668.28 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - |
| 10 | Coya Therapeutics | 114.94 Mn | 71.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.18 Mn |
| Mar 31, 2026 | 1.29 Mn |
| Dec 31, 2025 | 1.48 Mn |
| Sep 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 1.55 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | 991,941.00 |
| Sep 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 1.50 Mn |